Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Labopharm and Sepracor to develop solid oral form of levalbuterol

Jan. 23, 1997

New antiasthma agents from Tanabe Seiyaku

Jan. 23, 1997

SmithKline Beecham reports new antiinflammatory/antiallergic agents

Jan. 23, 1997

TBC cell adhesion inhibitor enters clinic

Jan. 22, 1997

Celltech reports new PDE IV inhibitors

Jan. 21, 1997

cAMP PDE inhibitors disclosed by Nippon Kayaku

Jan. 20, 1997

Therapeutically active glycomimetic saccharopeptides from Glycomed

Jan. 17, 1997

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

New antihistamines in the pipeline at HMR

Jan. 16, 1997

Inhale/Centeon agreement for alpha1-proteinase inhibitor

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...